Pneumococcal Conjugate Vaccine (13-Valent) and Zostavax Subcutaneous
Determining the interaction of Pneumococcal Conjugate Vaccine (13-Valent) and Zostavax Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pneumococcal 13-valent vaccine
Brand name: Prevnar 13
Synonyms: Pneumococcal 13-valent conjugate vaccine
Generic Name: zoster vaccine live
Brand name: Zostavax
Synonyms: Zostavax
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pneumococcal Conjugate Vaccine (13-Valent)-Zoster Vaccine (Live/Attenuated)
- Pneumococcal Conjugate Vaccine (13-Valent)-Zoster Vaccine (Recombinant)
- Pneumococcal Conjugate Vaccine (13-Valent)-Zoster vaccine inactivated
- Pneumococcal Conjugate Vaccine (13-Valent)-Zoster vaccine live
- Pneumococcal Conjugate Vaccine (13-Valent)-Zoster vaccine recombinant, adjuvanted Intramuscular
- Pneumococcal Conjugate Vaccine (13-Valent)-Zoster vaccine, live Subcutaneous
- Zostavax Subcutaneous-Pneumococcal Conjugate Vaccine (7-Valent)
- Zostavax Subcutaneous-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Zostavax Subcutaneous-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Zostavax Subcutaneous-Pneumovax 23
- Zostavax Subcutaneous-PNV - Omega
- Zostavax Subcutaneous-PNV Iron Polysaccharides, Folic Acid, DHA